Get started
Author

Hakob Atshemyan

Culture Conversion in Patients Treated with Bedaquiline and/or Delamanid. A Prospective Multicountry Study
2020 · Molly F. Franke, Palwasha Khan, et al. · American Journal of Respiratory and Critical Care Medicine · 62
High prevalence of infection and low incidence of disease in child contacts of patients with drug-resistant tuberculosis: a prospective cohort study
2018 · Helena Huerga, Elisabeth Sanchez-Padilla, et al. · Archives of Disease in Childhood · 21
PDF
Estimating Post-treatment Recurrence After Multidrug-Resistant Tuberculosis Treatment Among Patients With and Without Human Immunodeficiency Virus: The Impact of Assumptions About Death and Missing Follow-up
2023 · Sara M Sauer, Carole D Mitnick, et al. · Clinical Infectious Diseases · 11
PDF
Concomitant Treatment of Chronic Hepatitis C With Direct-Acting Antivirals and Multidrug-Resistant Tuberculosis Is Effective and Safe
2021 · Nara Melikyan, Helena Huerga, et al. · Open Forum Infectious Diseases · 11
Setting up pharmacovigilance based on available endTB Project data for bedaquiline
2020 · N. Lachenal, C. Hewison, et al. · The International Journal of Tuberculosis and Lung Disease · 11
The Management of Linezolid-Induced Adverse Events in Shorter and Longer Treatment of Rifampicin-Resistant Tuberculosis
2025 · Hakob Atshemyan, Naira Khachatryan, et al. · Annals of Pharmacotherapy · 3
The safety of modified, all-oral shorter tuberculosis regimens in Armenia
2024 · Hakob Atshemyan, Naira Khachatryan, et al. · International Journal of Risk & Safety in Medicine · 2
Lymphoproliferative skin lesion as a previously unreported adverse event detected in a patient receiving mSTR TB treatment
2022 · Hakob Atshemyan, Naira Khachatryan, et al. · Journal of Pharmacovigilance and Drug Research · 1
Integrating hepatitis C treatment into multidrug-resistant TB care
2022 · O. Kirakosyan, N. Melikyan, et al. · Public Health Action · 1
The Impact of Covid-19 Pandemic on the Detection of Tuberculosis in Armenia
2022 · Naira Khachatryan, Hakob Atshemyan, et al. · Journal of Tuberculosis Research · 1
PDF
Comparison of 3 Linezolid Management Strategies for Peripheral Neuropathy in Multidrug- or Rifampicin-Resistant Tuberculosis Treatment: A Target Trial Emulation
2026 · Matthew Romo, Allison LaHood, et al. · Clinical Infectious Diseases
A combined statistical analysis based on the active pharmacovigilance and disproportionality assessment for the safety of fluoroquinolones in shorter treatment of rifampicin-resistant tuberculosis
2026 · Hakob Atshemyan · Naunyn-Schmiedeberg s Archives of Pharmacology
Paradoxical responses to modified, all-oral shorter treatment of tuberculosis in non-immunocompromised patients: Cases from Armenia
2025 · Hakob Atshemyan, Naira Khachatryan, et al. · International Journal of Risk & Safety in Medicine
Works count: 14
Citation count: 124
H-index: 5
I10-index: 5
Year
Topic
Type